| Sale of goods and services | 56,158.49a | 48,271.99a |
| Other income | 122.95a | 126.3a |
| Operating expenses - direct | -51,319a | -44,032.51a |
| Net gain from changes in fair value of biological assets | 176.05a | 66.3a |
| Depreciation and amortisation | -755.66a | -721.01a |
| Other expenses | -2,585.56a | -2,169.09a |
| Finance income | 181.74a | 157.97a |
| Finance costs | -1,757.9a | -1,291.06a |
| Share of results from joint ventures and associates | -19.65a | 1.97a |
| Profit before taxation | 201.47a | 410.88a |
| Income tax expense | -73.14a | -59.88a |
| Profit for the financial year | 128.33a | 351a |
| Attributable to | — | — |
| Owners of the company | 86.42a | 278.72a |
| Non-controlling interests | 41.91a | 72.28a |